← Back to Conditions

Familial multiple lipoprotein-type hyperlipidemia

disorder
SNOMED 299465007CUI C0020474

Overview

Familial multiple lipoprotein-type hyperlipidemia is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Treatments & Interventions

Ezetimibe

substance

Mipomersen

substance

Mipomersen sodium

substance

Clinical Trials

1
Total Trials
0
Recruiting
0
With Results

Recent Trials

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

NCT00754039Phase 4Completed129 enrolled
View all 1 trials on ClinicalTrials.gov

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Xanthelasma of periocular region
Occasional (5-29%)HP:0001114
Elevated circulating apolipoprotein A-II concentration
HP:0031800
Elevated circulating apolipoprotein B concentration
HP:0031798
Elevated total cholesterol
HP:0003124
Hyperlipidemia
HP:0003077
Increased circulating very-low-density lipoprotein levels
HP:0003362
Increased plasma LDL levels
HP:0003141
Myocardial infarction
HP:0001658

Related Conditions

Hyperlipidemia(parent)

Quick Facts

SNOMED CT
299465007
UMLS CUI
C0020474
Fully Specified Name
Familial multiple lipoprotein-type hyperlipidemia (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
8
Known Treatments
3
Clinical Trials
1
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.